Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“.
Cellbyte is a Y Combinator company in the Winter 2022 batch. Its directory entry describes it as: AI Agents for Pharma Drug Launches. The founder listed is Felix Steinbrenner (Founder/CEO) (Y Combinator directory entry, January 25, 2022).
Sell to companies like Cellbyte? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2022-01-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Cellbyte.
Free to see. No signup.
More on Cellbyte and the records around it.
Same batch, Healthcare first.
Get an email when Cellbyte changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Cellbyte raises, hires or launches. No email unless you switch it on.
Watch Cellbyte →Get the full cited report on Cellbyte
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cellbyte: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cellbyte: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cellbyte covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CellbyteYou get an alert in MentionFox the next time this company shows up.
If you're behind Cellbyte: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for Cellbyte. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-cellbyte